Abstract:Stress, a common phenomenon in today’s society, is suspected of playing a role in the development of disease. Stressors of various types, psychological, physical, and biological, abound. They occur in the working and social environments, in air, soil, water, food, and medicines. Stressors impact on cells directly or indirectly, cause protein denaturation, and elicit a stress response. This is mediated by stress (heat-shock) genes and proteins, among which are those named molecular chaperones because they assist other proteins to achieve and maintain a functional shape (the native configuration), and to recover it when partially lost due to stress. Denatured proteins tend to aggregate and precipitate. The same occurs with abnormal proteins due to mutations, or to failure of post-transcriptional or post-translational mechanisms. These abnormal proteins need the help of molecular chaperones as much as denatured molecules do, especially during stress. A cell with normal antistress mechanisms, including a complete and functional set of chaperones, may be able to withstand stress if its intensity is not beyond that which will cause irreversible protein damage. There is a certain threshold that normal cells have above which they cannot cope with stress. A cell with an abnormal protein that has an intrinsic tendency to misfold and aggregate is more vulnerable to stress than normal counterparts. Furthermore, these abnormal proteins may precipitate even in the absence of stress and cause diseases named proteinopathies. It is possible that stress contributes to the pathogenesis of proteinopathies by promoting protein aggregation, even in cells that possess a normal chaperoning system. Examples of proteinopathies are age-related degenerative disorders with protein deposits in various tissues, most importantly in the brain where the deposits are associated with neuronal degeneration. It is conceivable that stress enhances the progression of these diseases by facilitating protein unfolding and misfolding, which lead to aggregation and deposition. A number of reports in the last few years have described research aimed at elucidating the role of heatshock proteins, molecular chaperones in particular, in the pathogenesis of neurodegenerative disorders. The findings begin to shed light on the molecular mechanism of protein aggregation and deposition, and of the ensuing cell death. The results also begin to elucidate the role of molecular chaperones in pathogenesis. This is a fascinating area of research with great clinical implications. Although there are already several experimental models for the study of proteinopathies, others should be developed using organisms that are better known now than only a few years ago and that offer unique advantages. Use of these systems and of information available in databases from genome sequencing efforts should boost research in this field. It should be possible in the not-too-distant future to develop therapeutic and preventive means for proteinopathies based on the use of heat-shock protein and molecular chaperone genes and proteins.

Protein thermal sensing regulates physiological amyloid aggregation

PI3K/AKT Signaling Mediates Stress-Inducible Amyloid Aggregation Through c-myc

Temperature-Dependent Structural Variability of Prion Protein Amyloid Fibrils

Modulation of Alzheimer's Disease Aβ40 Fibril Polymorphism by the Small Heat Shock Protein αB-Crystallin

Proteins in Aggregates Functionally Impact Multiple Neurodegenerative Disease Models by Forming Proteasome-Blocking Complexes

Exploring the Effect of Temperature and Peptide Chain Number on the Stability of Aβ42 Mutants Through Multidimensional Analysis

Stress and molecular chaperones in disease

Hsp70–Bag3 complex is a hub for proteotoxicity-induced signaling that controls protein aggregation

The Molecular Chaperone αB-crystallin Enhances Amyloid β Neurotoxicity

Thermodynamic Stability Modulates Chaperone-Mediated Disaggregation of α-Synuclein Fibrils

Conformational change in the C-terminal domain is responsible for the initiation of creatine kinase thermal aggregation.

Protein rescue from aggregates by powerful molecular chaperone machines

Heat Shock Gene Inactivation and Protein Aggregation with Links to Chronic Diseases

αB-crystallin, a small heat-shock protein, prevents the amyloid fibril growth of an amyloid β-peptide and β2-microglobulin

Cell surface protein aggregation triggers endocytosis to maintain plasma membrane proteostasis

Small Heat Shock Proteins, Big Impact on Protein Aggregation in Neurodegenerative Disease

Long-range Regulation of Partially Folded Amyloidogenic Peptides

Prevention of amyloid‐like aggregation as a driving force of protein evolution

The role of α-sheet structure in amyloidogenesis: characterization and implications

Chaperones in control of protein disaggregation

Spatial sequestration of misfolded proteins as an active chaperone-mediated process during heat stress